20 February 2022
: Case report 
Relapsing Infectious Mononucleosis-Like Symptoms Associated with Liver Insufficiency in a Chronic Hepatitis B Patient with Common Variable Immunodeficiency
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment
Akira Sato1ABCDEF*, Fumiaki Sano2CD, Hideaki Takahashi1B, Nobuyuki Matsumoto1BDOI: 10.12659/AJCR.934003
Am J Case Rep 2022; 23:e934003
Table 1. Laboratory data before treatment with propagermanium (Feb. 2010).
| Hematology | Range | ||
|---|---|---|---|
| WBC | 68 | ×10/µL | 36–96 |
| Neut | 74 | % | 40–71 |
| Ly | 16 | % | 27–47 |
| Mono | 8 | % | 2–8 |
| Eo | 1.5 | % | 1–7 |
| Ba | 0.5 | % | 0–1 |
| Hb | 9.4 | g/dL | 11.2–14.9 |
| RBC | 417 | ×10/µL | 378–497 |
| Hct | 28.5 | % | 33.6–44.6 |
| Plt | 13.9 | ×10/µL | 12.5–37.5 |
| Viral markers | |||
| HBsAg | >2000 | C.O.I. | <0.05 |
| HBeAg | (−) | (−) | |
| HBeAb | (+) | (−) | |
| HBV DNA | 6.9 | log IU/mL | <2.6 |
| HIVAb ½ | (−) | (−) | |
| Biochemistry | Range | ||
| T-Bil | 0.5 | mg/dL | 0.2–1.2 |
| AST | 53 | IU/L | 11–32 |
| ALT | 51 | IU/L | 7–37 |
| LDH | 164 | IU/L | 115–230 |
| ALP | 367 | IU/L | 115–360 |
| γ-GTP | 31 | IU/L | 4–36 |
| TP | 6.4 | g/dL | 6.7–8.3 |
| ALB | 4.5 | g/dL | 4.0–5.1 |
| Protein fraction (Sept. 2006) | |||
| TP | 6.5 | g/dL | 6.7–8.3 |
| Albumin | 71.1 | % | 62.0–72.0 |
| α1 | 3.8 | % | 2.0–3.0 |
| α2 | 7.9 | % | 5.0–9.0 |
| β | 11.5 | % | 7.0–11.0 |
| γ | 5.7 | % | 11.0–20.0 |